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 2 
Abstract 29 
Current methods to quantify in vivo RNA dynamics are limited. Here, we developed a 30 
novel stable isotope (D2O)-methodology to quantify RNA synthesis (i.e. ribosomal 31 
biogenesis) in cells, animal models, and humans. Firstly, proliferating C2C12 cells were 32 
incubated in D2O-enriched media and myotubes (±) 50ng.ml
-1
 IGF-1. Secondly, rat 33 
quadriceps [untrained n=9; 7-wks interval-“like” training n=13] were collected after ~3-34 
wks D2O (70-Atom%) administration, with body-water enrichment (BWE) monitored 35 
via blood sampling. Finally, 10 (23±1y) men consumed 150ml D2O followed by 36 
50ml/wk and undertook 6-wks resistance-exercise (RE; 6×8 repetitions, 75%-1RM 37 
3/wk) with BWE monitored by saliva sampling and muscle biopsies (for determination 38 
of RNA synthesis) 0-3-6-wks. Ribose mole percent excess (r-MPE) from purine 39 
nucleotides was analyzed via GC-MS/MS. Proliferating C2C12 cells r-MPE exhibited a 40 
rise-to-plateau while IGF-1 increased myotube RNA from 76±3ng/ul to 123±3ng/ul and 41 
r-MPE by 0.39±0.1% (both P<0.01). After 3-wks, rat quadriceps r-MPE had increased 42 
to 0.25±0.01% (P<0.01) and was greater with running-exercise (0.36±0.02%; P<0.01)). 43 
Human muscle r-MPE increased to 0.06±0.01% and 0.13±0.02% at 3/6-wks 44 
respectively equating to synthesis rates of ~0.8%/d, increasing with RE to 1.7±0.3%/d 45 
(P<0.01) and 1.2±0.1%/d (P<0.05) at 3/6-wks, respectively. Therefore, we have 46 
developed and physiologically validated a novel technique to explore ribosomal 47 
biogenesis in a multi-modal fashion. 48 
 49 
 50 
 51 
 52 
 3 
Introduction 53 
Cellular protein content is under constant renewal to maintain cellular homeostasis. 54 
Typically, the balance between protein synthesis and breakdown remains relatively 55 
stable, yet under conditions of growth, atrophy or cellular proliferation, rapid and 56 
significant changes in protein content and cell size occur (5). With protein synthesis 57 
rates determined by the number (translational capacity) and activity (translational 58 
efficiency) of ribosomes (27, 39), the ribosome provides a primary point of control in 59 
cellular homeostasis; yet our understanding of dynamic ribosome metabolism is poorly 60 
understood. Ribosomal biogenesis is the product of the coordinated synthesis of 61 
multiple ribosomal RNA’s (rRNA) and proteins. In being an energy consuming process, 62 
ribosomal biogenesis is tightly regulated by multiple signaling pathways responsive to 63 
nutrition, hormones and mechanical activity (22). However, basal rates of ribosomal 64 
biogenesis and ribosome half-life across tissues are for the most part largely 65 
undescribed. With the demands to modulate and maintain protein content varying 66 
considerably across cell types, such as rapidly dividing single cells, to the coordinated 67 
maintenance repair of multicellular organs, regulation of ribosome pools is likely to be 68 
tightly linked with protein metabolism (10). Furthermore, when the coordinated control 69 
of ribosome biogenesis becomes unregulated it can be the source of many conditions 70 
such as cancer (30). 71 
 72 
Skeletal muscle is one of the body’s most plastic tissues, undergoing substantial and 73 
rapid hypertrophy or atrophy under conditions of functional overload, disuse or 74 
malnutrition (2, 9, 17). Understanding these processes is of great importance as 75 
preservation of muscle mass and function throughout life is crucial in preventing 76 
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disability and maintaining quality of life- particularly in advanced ageing (16, 31). In 77 
being a post-mitotic tissue, muscle mass is controlled by the balance between muscle 78 
protein synthesis (MPS) and muscle protein breakdown (MPB). Many acute changes in 79 
MPS (< 5h) are accompanied by the activation or suppression of proteins in the 80 
mTORc1 pathway (1), modulating translational efficiency rather than translational 81 
capacity (6). However, prolonged exposure to muscle loading modifies RNA content – 82 
increasing with hypertrophy (3, 12, 34) and decreasing with atrophy (15). As such, 83 
ribosomal biogenesis is thought to be central to muscle mass regulation. 84 
 85 
With rRNA comprising 80% of total RNA, changes in RNA concentration are thought 86 
to be indicative of changes in the balance of ribosome synthesis and breakdown. 87 
However in addition to relying on long-term interventions, efficient extraction and 88 
normalization to muscle weight introducing variability, measures of concentration do 89 
not inform on dynamic RNA metabolism, plus changes in RNA synthesis naturally 90 
precede those of content. Past measures of RNA synthesis have typically relied on the 91 
incorporation of modified nucleotides such as [3H]-uridine or 5-bromouridine. However 92 
the use of these techniques is limited and generally cannot be used in whole animals due 93 
to their mutagenic nature. Alternatively, stable isotope tracers offer a safe method for 94 
use in humans and measures of RNA synthesis using these have been made (8, 14). Yet 95 
their applicability in human research has been limited due to numerous caveats, 96 
including variable and complex salvage pathways, infusions and time limits (<24h) 97 
resulting in a lack of methods to determine RNA synthesis rates, particularly in tissues 98 
with slow renewal rates (like skeletal muscle). Heavy water (D2O) provides alternate 99 
routes in the measurement of substrate metabolism and can overcome some limitations 100 
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associated with other stable isotope methods. In being easily administered and with the 101 
precursor pool being maintained over weeks to months, we and others have made long-102 
term cumulative measures of muscle protein synthesis (32, 40), with many other 103 
substrates measured in a range of different tissues including DNA (23, 29). Deuterium 104 
is incorporated via nucleotide de novo synthesis, overcoming previous limitations of 105 
nucleotide analogues and thus similarly creates a viable route in the measurement of 106 
RNA synthesis.  Here, we developed sensitive GC-MS/MS universally applicable 107 
methods for the measurement of RNA synthesis including in slower turning over tissues 108 
requiring only minimal D2O consumption; we validate these methods in cell cultures, 109 
pre-clinical models and humans and in a cell type of contemporary interest i.e. skeletal 110 
muscle. 111 
 112 
Materials and Methods 113 
 114 
Cell culture 115 
Murine C2C12 myoblasts passage nos. 5-7; ECACC, Salisbury, UK were seeded and 116 
maintained in Dulbecco’s modified Eagle’s medium as previously described (7) 117 
containing 10% fetal bovine serum, amphoteracin B (1%), penstreptomycin (1%) and 118 
4mM L-glutamine (Sigma-Aldrich, UK). Sterile 70% deuterium and U-
13
C-Glucose 119 
were added to DMEM at required enrichments and distributed amongst wells for 120 
labeling consistency. In proliferating cells, media was changed every 48h and cells 121 
scraped at required time points. At 90% confluency, cells were differentiated by 122 
reducing serum concentrations to 2% with RNA synthesis stimulated 6 days after 123 
differentiation with IGF1 50 ng.ml
-1
.  124 
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 125 
Animals  126 
Mixed population of females and males n=22 of high responder to training (HRT) rats 127 
for aerobic training were used for the study. Rats originated from the generations 17 and 128 
18 of selection for their training response, and were 9.2 ± 3.0 months old at the start of 129 
the experiment (21). All experimental procedures described in this study protocol were 130 
approved by the Animal Care and Use Committee of the Southern Finland, license 131 
number ESAVI-2010-07989/Ym-23, STH 534A (21.9.2010) and complements 132 
ESAVI/1968/04.10.03/2011, PH308A (30.3.2011) & ESAVI/722/04.10.07/2013, 133 
PH275A (1.3.2013). All experiments were conducted in accordance with the Guidelines 134 
of the European Community Council directive 86/609/EEC. Rats were kept in air-135 
conditioned rooms single-housed, at an ambient temperature of 21 ±2 °C and the 136 
relative humidity at 50 ± 10 %. Artificial lighting provided light cycles of 12 h light/12 137 
h total darkness. Commercially available pelleted rodent diet (R36, Labfor/Lantmännen, 138 
Malmö, Sweden) and the tap water (from the municipal water system of Jyväskylä) was 139 
available ad libitum for rats throughout the study. The energy content of the feed was 140 
1260 kJ/100 g (300.93 kcal/100g). The feed contained raw protein 18.5%, raw fat 4.0%, 141 
NFE (nitrogen free extracts) 55.7%, fiber 3.5%, ash 6.3%, and water <12%. Rats 142 
received a gavage of 7.2 ml/kg of 70% D2O for the remaining 3 wks of the 7 wk 143 
training period, with drinking water enriched to 2% to maintain body water enrichment. 144 
Body water enrichment was determined from blood samples collected at necropsy and 145 
used to represent the average enrichment throughout; although variability may occur 146 
over time, enriched drinking water minimizes these effects. Interval Training consisted 147 
of Warm-up for 5 min, at 50-60% of maximum speed (individually speed for each rat) + 148 
 7 
running for 15 min: 3 min at 85 - 90%, 2 min pauses at 50%, repeated for 3 times; 149 
inclination 15
o
 uphill. Training was done 3 times per week, with one-day rest between 150 
(if possible). 48 hrs after the last training bout animals were anaesthetized with carbon 151 
dioxide and killed by cardiac puncture and thereafter immediately necropsied. Left 152 
quadriceps were rapidly exposed, removed and immediately frozen by complete 153 
immersion in liquid nitrogen. 154 
 155 
Subject characteristics and ethics  156 
Ten healthy younger (23±1y, BMI: 24±1) men were recruited as previously described 157 
(3). All subjects provided their written, informed consent to participate after all 158 
procedures and risks (in relation to muscle biopsies, blood sampling etc.) were 159 
explained. Following inclusion to the study, subjects were studied over a 6-week period. 160 
After baseline bilateral biopsies, subjects provided a saliva and blood sample then 161 
consumed 150 ml D2O (70 atom%; Sigma-Aldrich, Poole, UK) to label the body water 162 
pool to ~0.2% APE which was maintained with weekly top-up boluses (50 ml.wk
-1
). 163 
Thereafter subjects performed progressive unilateral RET 3/wk at 75% 1RM, with 164 
additional bilateral biopsies taken at 3 and 6 wks to monitor RNA incorporation. Blood 165 
was collected at 0, 3 and 6 weeks to follow deuterium incorporation into peripheral 166 
blood mononuclear cells, isolated using Histopaque (Sigma). For the temporal 167 
monitoring of body water enrichment, each participant provided a saliva sample on RET 168 
visits >30 min after their last meal or drink, with extra samples taken ~3 h after weekly 169 
50 ml boluses to ensure that body water enrichment was accurately represented. 170 
Samples were collected in sterile plastic tubes and immediately cold centrifuged at 171 
16,000g to remove any debris that might be present; they were then aliquoted into 2ml 172 
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glass vials and frozen at -20°C until analysis. This study was approved by The 173 
University of Nottingham Ethics Committee and complied with studies conducted in 174 
accordance with the declaration of Helsinki and registered as clinical trials 175 
(clinicaltrials.gov registration no. NCT02152839).  176 
 177 
Media and body water enrichment  178 
The deuterium enrichment was measured in media collected from cell culture plates and 179 
plasma from rats by incubating 100µl of each sample with 2µl of 10 M NaOH and 1µl 180 
of acetone for 24 h at room temperature. Following incubation the acetone was 181 
extracted into 200µl of n-heptane, and 0.5µl of the heptane phase was injected into the 182 
GC-MS/MS for analysis. A standard curve of known D2O enrichment was run along 183 
side the samples for calculation of enrichment. Human body water enrichment was 184 
extracted by heating 100 µl saliva in an inverted 2 ml autosampler vial for 4 h at 100°C. 185 
Vials were then placed upright on ice to condense extracted body water and transferred 186 
to a clean autosampler vial ready for injection. A total of 0.1µl body water was injected 187 
into a high-temperature conversion elemental analyzer (Thermo Finnigan; Thermo 188 
Scientific, Hemel Hemp- stead, United Kingdom) connected to an isotope ratio mass 189 
spectrometer (Delta V Advantage; Thermo Scientific) 190 
 191 
Protein-bound alanine muscle fraction enrichment and calculation of FSR 192 
Myofibrillar protein was isolated from human VL muscle biopsies and rat quadriceps by 193 
homogenizing 30–50 mg muscle in ice-cold homogenization buffer, rotated for 10min, 194 
and the supernatant collected after centrifugation at 13,000 g for 5 min at 4°C. The 195 
myofibrillar pellet was solubilized in 0.3 M NaOH and separated from the insoluble 196 
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collagen by centrifugation, and the myofibrillar protein was precipitated using 1 M 197 
perchloric acid (PCA). Protein-bound amino acids were released using acid hydrolysis 198 
by incubating in 0.1 M HCl in Dowex H+ resin slurry overnight before being eluted 199 
from the resin with 2 M NH4OH and evaporated to dryness; amino acids were then 200 
derivatised as their N-methoxycarbonyl methyl esters. Dried samples were suspended in 201 
60 µl distilled water and 32 µl methanol, and following vortex, 10 µl pyridine and 8 µl 202 
methylchloroformate were added. Samples were vortexed for 30 s and left to react at 203 
room temperature for 5 min. The newly formed N- methoxycarbonylmethyl ester amino 204 
acids were then extracted into 100 µl chloroform. A molecular sieve was added to each 205 
sample for ~20 s before being transferred to a clean glass gas chromatography insert, 206 
removing any remaining water by size exclusion absorption. Human protein-bound 207 
alanine enrichment was determined by gas chromatography: pyrolysis:isotope ratio 208 
mass spectrometry (Delta V Advantage Thermo Finnigan, Thermo Scientific, Hemel 209 
Hempstead, UK), with rat protein-bound alanine enrichment determined by gas 210 
chromatography tandem mass spectrometry (TSQ 8000 Thermo Finnigan, Thermo 211 
Scientific, Hemel Hempstead, UK) alongside a standard curve of known DL-Alanine-212 
2,3,3,3-d4 enrichment to validate measurement accuracy of the machine. Myofibrillar 213 
MPS was calculated from the incorporation of deuterium-labeled alanine into protein, 214 
using the enrichment of body water [corrected for the mean number of deuterium 215 
moieties incorporated per alanine (3.7) and the dilution from the total number of 216 
hydrogens in the derivative (i.e., 11)] as the surrogate precursor labeling between 217 
subsequent biopsies. The equation used was  218 
 𝐹𝑆𝑅 = −𝐿𝑛 (
1 −  [
(𝐴𝑃𝐸𝑎𝑙𝑎)
(𝐴𝑃𝐸𝑝)
]
𝑡
) 
 10 
where APEala equals deuterium enrichment of protein-bound alanine, APEp indicates 219 
mean precursor enrichment over the time period, and t is the time between biopsies. 220 
 221 
RNA extraction, digestion and derivatisation 222 
To extract RNA, ~20-30mg of muscle was homogenized in extraction buffer (5µl/mg) 223 
containing 0.1 M Tris-HCL pH 8, 0.01 M EDTA pH 8 and 1M NaCL. Proteinase K was 224 
added to a final concentration of 50 µg/µl and placed at 55
o
C for ~2 hrs with occasional 225 
mixing until complete digestion had occurred. For cell culture, each well was scraped in 226 
200 µl of extraction buffer and PBMC’s homogenized in 200 µl of extraction buffer. To 227 
the extractions an equal volume of phenol:chloroform:isoamyl alcohol  (25:24:1) was 228 
added, inverted several times to mix and the upper aqueous layer removed to a clean 229 
eppendorf after centrifugation at 13000 rpm for 10 min. To remove additional protein 230 
an equal volume of chloroform:isoamyl alcohol (24:1) was added to the aqueous layer 231 
and repeated as above. To precipitate RNA, an equal volume of isopropanol was added 232 
to the aqueous layer, inverted several times and centrifuged at 13000 rpm for 20 min. 233 
The pellet was washed 3 times in 70% ethanol; air-dried, re suspended in 22 µl of 234 
molecular biology and digested with 5 µl of 375 mM sodium acetate (pH 4.8), 750 µM 235 
ZnSO4 containing 0.5 units of nuclease S1 and 0.25 units potato acid phosphatase and 236 
placed at 37
o
C overnight. Hydrolysates were then reacted with 10 µl of O-237 
benyzylhyrdoxylamine (2% w/v) and 7.5 µl of acetic acid at 100
o
C for 30 min. Samples 238 
were allowed to cool at room temperature before the addition of 10µl of 1-239 
methyimidazole and 100 µl of acetic anhydride. The reactions are transferred to a 240 
boiling tubed and quenched by the addition of 2 ml ddH2O. The newly formed 241 
derivatives were extracted by the addition of 750 µl dichloromethane (DCM) vortex 242 
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mixed and phases allowed to separate. By pre wetting the tip with DCM, the lower layer 243 
is removed to a clean boiling tube and the procedure repeated.  DCM extracts were then 244 
dried and re suspended in 40 µl of ethyl acetate for GC-MS/MS analysis. 245 
 246 
GC-MS/MS instrument conditions and fractional synthesis rate calculation 247 
To measure RNA enrichment 2 µl of sample was injected into a trace 1310 gas 248 
chromatograph connected to TSQ 8000 triple quadrupole GC-MS/MS (Thermo 249 
Finnigan, Thermo Scientific, Hemel Hempstead, UK). Samples were injected on 250 
splitless mode with inlet temperature at 280
o
C. GC ramp conditions were 120
o
C for 1 251 
min, ramp to 280
 o
C at 10
 o
C /min and hold for 3 min. Selected reaction monitoring 252 
(SRM) was performed for the mass to charge ratios m/z of 273.1-111.1 and 274.1-112.1 253 
representing the M and M
+1
 ions with a collision induced dissociation energy of 6. 254 
Enrichment was calculated as (M
+1
/ (M + M
+1
) with the mole percent excess (MPE) 255 
expressed as difference from unlabeled D2O free samples. Fractional synthesis rates 256 
were calculated as FSR(%.d
-1
) = (r-MPE)/[(p-MPE) x t] x 100 where r-MPE is the 257 
excess enrichment of bound ribose, p-MPE is the mean precursor enrichment over the 258 
time period and t is the time between samples. In cell culture and rat studies, p-MPE 259 
was calculated as the water enrichment multiplied by the amplification factor of 2.098 260 
determined in cells. In human studies, p-MPE was taken as the ribose PBMC 261 
enrichment measured over the labeling period. Samples were run in triplicate alongside 262 
standard curves of known ribose standards, with the average of both peaks were used in 263 
the results. Additionally, unlabeled samples were injected in different quantities to 264 
determine abundance effects.  265 
 266 
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Statistical Analysis  267 
Descriptive statistics were produced for all data sets to check for normal distribution 268 
(accepted if P>0.05) using a Kolmogorov-Smirnov test. All data are presented as means 269 
± SEM. Differences between the effects of interval training and control on RNA 270 
synthesis in rates were analyzed by t-test. All other data sets were analyzed by repeated 271 
measures one-way or two-way ANOVA with a Bonferroni correction using GraphPad 272 
Prism (La Jolla, CA) Software Version 5. Correlations were assessed using Pearsons 273 
product moment correlation coefficient. The α level of significance was set at P<0.05. 274 
  275 
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Results 276 
 277 
GC-MS/MS chromatography and SRM transitions  278 
Addition of O-benyzylhyrdoxylamine and 4 acetyl groups to ribose produces a 279 
derivative with a molecular weight of 423.1 (Fig 1A). Upon gas chromatography the 280 
derivative produces two peaks representing the cis-trans isomers formed due to the 281 
anomeric carbon of ribose (Fig 1B). Full scan MS analysis of the derivative produces a 282 
most abundant fragment with best chromatography of 273.1, with second 283 
fragmentation producing a most abundant fragment of 111.1. Analysis of this transition 284 
is highly selective and produces GC-MS/MS spectra with very low background, 285 
detecting standard enrichments as little as 0.02 APE (Fig 1C). Further this SRM 286 
encompasses all backbone carbons of ribose confirmed by +5 enrichment from U-
13
C-287 
Glucose incorporation (Fig 1D). 288 
 289 
Deuterium incorporation into RNA bound ribose  290 
The MPE of ribose (Fig 2A) extracted from purine nucleotides of RNA from C2C12 291 
cells increased linearly with increasing concentrations of media D2O enrichment being 292 
0%, 1.6±0.08%, 4.1±0.1%, 9.5±0.15%, 18.8±0.18% at media concentrations of 0% 293 
0.67%, 1.9%, 4.6% and 8.9% respectively. Linear regression revealed that on average 294 
2.1 
2
H are incorporated into purine ribose during synthesis of new RNA. PBMC’S from 295 
human subjects showed an increase in MPE to 0.37±0.04% and 0.42±0.04% (both 296 
P<0.01), revealing the average accessible hydrogen’s to be 2.6±0.2 (Fig 2B).  297 
 298 
Validation of deuterium incorporation in RNA in vitro 299 
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C2C12 cell number increased from 0.083±0.001 million per well to 1.2 ±0.03 million 300 
after 117 h of proliferation (Fig 3A), whilst RNA MPE followed a rise to plateau 301 
relationship from 0.28±0.03% after 15 h and progressed to 0.52±0.02% by 117 h (Fig 302 
3B). In response to IGF1 treatment, RNA content increased by 27.5 h from 76.1±3 303 
ng.ul
-1
 to 123.4±3 ng.ul
-1 
(Fig 3C). Similarly, RNA MPE significantly increased in 304 
control to 0.15 ±0.01% at 27.5 h, with the increase in IGF1 treatment being significantly 305 
greater (Fig 3D). 306 
 307 
RNA Synthesis in rat muscle in vivo 308 
After 3 weeks of continuous D2O administration, RNA MPE significantly increased to 309 
0.25±0.01% in control and was significantly greater with interval training to 310 
0.36±0.01% P<0.001 (Fig 4A). The calculated RNA FSR was 0.97±0.05 %.d
-1
 with a 311 
significant increase in response to interval training to 1.3±0.05 %.d
-1 
P<0.001 (Fig 4B). 312 
Rat quadriceps MPS showed a correlation with quadriceps RNA synthesis % of r
2
=0.17 313 
and P=0.05 314 
 315 
RNA synthesis in human muscle  316 
The MPE from RNA bound ribose increased in rest legs to 0.064 ±0.01% and 0.137 317 
±0.02% at 3 and 6 weeks respectively (P<0.001). In RET legs, the MPE increased to 318 
0.125 ±0.02% and 0.211 ±0.01% at 3 and 6 week respectively (P<0.001), being greater 319 
than rest at both time points (P<0.005). Corrected for PBMC RNA enrichment an FSR 320 
of 0.86 ±0.1%.d
-1
 and 0.78 ±0.1%.d
-1
 was determined in rest legs at 3 and 6 weeks 321 
respectively. In RET legs the RNA FSR was significantly greater than rest being 1.69 322 
 15 
±0.2 %.d
-1 
(P<0.01) and 1.24 ±0.1%.d
-1
 (P<0.05) at 3 and 6 weeks respectively. Human 323 
VL MPS was highly correlated with VL RNA synthesis P=0.009 and an r
2
=0.32. 324 
 325 
  326 
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Discussion 327 
 328 
We have developed and validated D2O-based methods for the measurement of in vitro 329 
and in vivo RNA synthesis that can be used safely and effectively in humans and with 330 
the potential for application to any tissue- this is a step forward from current practices in 331 
providing methods for long term measures of RNA synthesis in humans, particularly 332 
those of slow turnover pools such as skeletal muscle. RNA content is closely linked to 333 
cellular metabolism, with ribosomal biogenesis being required for cellular proliferation 334 
(10) and growth (34). Currently, changes in RNA content are primarily determined by 335 
crude measures of RNA concentrations, with limited methods in place to determine 336 
dynamic rates of RNA synthesis in vivo. Our approach will provide insight into the 337 
workings of dynamic ribosomal biogenesis in vitro, in animal models and in humans – 338 
across cell types. 339 
 340 
Method development and validation of in vitro RNA synthesis in skeletal muscle 341 
cells 342 
Nucleotide synthesis involves complex precursor pools with variable nucleotide salvage 343 
(23) making the incorporation of stable isotope labeled compounds difficult to interpret 344 
(13). The advantage of using D2O is that deuterium becomes incorporated into the 345 
backbone hydrogen of ribose during nucleotide synthesis, with deoxyribose from purine 346 
deoxyribonucleosides primarily synthesized via de novo synthesis; as such, providing a 347 
reliable input of isotope (23, 29). As deoxyribonucleotides are reduced from 348 
ribonucleotides, this further creates a viable method for measures of RNA synthesis and 349 
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for the first time we have shown a constant incorporation of deuterium across a range of 350 
media concentrations into purine ribose. 351 
 352 
Total RNA encompasses rRNA, tRNA and mRNA that will have variable turnover rates 353 
(33). The quickest of these will be tRNA and mRNA that will contribute to early 354 
increases in detectable enrichment. However in making up <20% of total cellular RNA, 355 
these pools become quickly saturated and deuterium incorporation follows a rise to 356 
plateau in proliferating cells reflecting the required expansion of rRNA for cell division 357 
(Fig 3B) (8, 10). Further, as initial validation using established stimulators of in vitro 358 
myotube hypertrophy and ribosomal biogenesis (i.e. IGF-1)(7), we were able to detect 359 
simultaneous increases in both RNA content and deuterium incorporation into RNA. 360 
Therefore, deuterium incorporation into RNA was reflective of newly synthesized 361 
RNA. 362 
 363 
To use precursor product calculations, a measure of the precursor, or a proxy thereof, is 364 
required (38). Alternatively, when using D2O, an amplification factor can be used to 365 
represent the amount of accessible hydrogen in the precursor that can incorporate 366 
deuterium and be multiplied by the body water enrichment (4). Nucleotide precursor 367 
pools are difficult to measure, with continuous input of unlabeled substrates such that 368 
the maximal theoretical plateau is never achieved (24). To investigate the number of 369 
accessible hydrogen in ribose in vitro, murine C2C12 skeletal muscle cells were 370 
repeatedly passaged in a range of D2O media enrichments, revealing a constant 371 
incorporation of ~2.1 deuterium’s out of a total 6. Previously, values of ~3.1 have been 372 
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reported for deoxyribose out of a total 7 (26, 29), expectedly higher due to the 373 
additional hydrogen that exchanges with ribonucleotide reductase.  374 
 375 
Validation of in vivo RNA synthesis in an animal model 376 
Compared to many tissues, skeletal muscle has a relatively slow habitual protein 377 
renewal rates, with little to no active DNA synthesis (11); in contrast actual RNA 378 
synthesis rates are practically unknown and will vary considerably across tissues. As 379 
D2O can be simply administered by oral consumption and easily maintained, D2O can 380 
be used to capture a vast range of synthesis rates. Recently, D2O has been used to 381 
measure ribosome renewal in mouse liver, although in using GC-MS this requires high 382 
levels of enrichment (5% APE) and fast rates of turnover (~10%) that can be 383 
burdensome and limit applications(25). Applying our validated in vitro methods to 384 
rodents, to our knowledge, we made the first long term measures of RNA synthesis in 385 
skeletal muscle. In doing so, we demonstrated there is active renewal of RNA pools of 386 
~1%.d
-1
. Furthermore, using an exercise stimulus to activate ribosomal biogenesis (39) 387 
we validated the existence of a significant increase in deuterium incorporation into 388 
RNA, demonstrating increased RNA synthesis. Intriguingly, RNA synthesis rates were 389 
correlated with MPS, which we speculate is due to a co-ordinate regulation in response 390 
to exercise. 391 
 392 
RNA Synthesis in Human Muscle and the Effect of Resistance Exercise  393 
Presumably most tissues will have a constant level of rRNA synthesis to maintain 394 
functional ribosomes for cellular protein synthesis. That said, since ribosome biogenesis 395 
consumes considerable energy and will therefore likely be maintained at minimal 396 
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requirements. Using the methods described here, to our knowledge we report the first 397 
measures of RNA synthesis in human muscle, showing a constant synthesis rate of ~0.8 398 
%.d
-1
 during “habitual activity”. Further, to asses precursor enrichment, we measured 399 
the plateau enrichment of a population of cells 100% replenished (PBMCS) over the 400 
labeling period (29). This accounts for individual variability in the number of accessible 401 
hydrogens and further we showed on average 2.6 deuterium’s were incorporated, 402 
similar to our in vitro measures. 403 
 404 
Skeletal muscle RNA content is highly responsive to functional overload (28, 37) and 405 
here we have shown that in response to RET, RNA synthesis was significantly 406 
increased after 3 and 6 weeks of exercise training in humans. Once again, RNA 407 
synthesis was correlated with MPS which further validates that in muscle, ribosome and 408 
protein metabolism are likely to be inextricably related (likely via mTORc1 (18)). 409 
Similarly, although there is little other data for us to compare our results to, whole body 410 
rRNA turnover determined by breakdown products in urine have been estimated ~2.5% 411 
(36). Further this showed a strong relationship between whole body protein degradation 412 
rates of r
2
=0.7 supporting that these are closely linked process in muscle homeostasis. 413 
 414 
Further Application of Methods for RNA synthesis 415 
Previously, measures of RNA synthesis have been made in humans using 6,6
2
H2-416 
Glucose, however this requires large amounts of tracer to be consumed (1g/Kg) and is 417 
generally limited to fast turnover cells (8). Further, achieving high levels of enrichment 418 
to perform GC-MS analysis in humans is costly, requiring high levels of D2O 419 
consumption that is burdensome on the individual and may potentially cause adverse 420 
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effects such as nausea and vertigo (19). Further, rates of RNA synthesis will vary 421 
considerably across tissues, making the detection of slow turnover pools such as muscle 422 
using GC-MS techniques difficult. Here, by combining sensitive GC-MS/MS 423 
techniques (detection limits of ≥0.02% MPE) and the ability to administer D2O from 424 
days to weeks, this method creates opportunities to measure RNA synthesis over a 425 
range of rates and tissues. Such measures can be employed through simple D2O 426 
administration and access to tissue samples or blood- with some prior expectation of 427 
synthesis helpful. For instance, human body water enrichment can be simply maintained 428 
~ 0.15-0.2% APE using an initial bolus of 150 ml D2O, followed by weekly doses of 50 429 
ml (3). In this situation, sampling from a tissue after 5 days with an RNA turnover rate 430 
of ~10 %.d
-1
 would result in an easily detectable product enrichment using GC-MS/MS 431 
of ~ 0.075-0.1%, whereas an RNA turnover rate of ~1 %.d
-1
 would result in an 432 
undetectable enrichment of ~ 0.0075%-0.01%. This is not to say these measure can’t be 433 
made by other means. Raising body water enrichment will increase end point 434 
enrichment and body water enrichments as high as 2% would make GC-MS techniques 435 
an option. However D2O consumption of such high levels is costly and burdensome on 436 
subjects. As such the methods used here can be readily applied to many situations.  437 
 438 
Conclusion  439 
In summary we have developed and validated the use of D2O in measurement of RNA 440 
synthesis both in vitro and in vivo. With many RNA synthesis rates unknown, these new 441 
methods will have a significant impact in being able to measure a wide range of RNA 442 
turnover rates in varied tissues. Further, ribosomal biogenesis has been the interest of 443 
recent publications in muscle adaptive mechanisms (12, 20, 34, 35)  and will likely play 444 
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a significant role elucidating muscle metabolism at rest and in response to 445 
hypertrophic/atrophic conditions. 446 
  447 
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Figure Legends 488 
Figure 1. A) Structure and mass of the ribose BHTA derivative. B) Typical GC-MS/MS 489 
chromatogram of the ribose derivative on a DB-17 column for the SRM transitions of 490 
(273.1-111.1). Blue line represents the M and red the M+1 C) Standard curve of 1-
13
C-491 
Ribose 0.02, 0.05, 0.1, 0.5 D) measurement of the +5 isotopomer of RNA bound ribose 492 
from C2C12 myotubes incubated in U-
13
C glucose enriched media 493 
 494 
Figure 2. A) MPE of RNA from maximally labeled C2C12’s vs. D2O media MPE and 495 
B) the amplification of deuterium into PBMC’S from human subjects. *** Significantly 496 
different from baseline P<0.001 497 
 498 
Figure 3. Time course of A) cell number B) MPE of RNA in proliferating C2C12’s. 499 
Time course in the concentration of C) RNA and D) MPE of RNA in non-treated 500 
condition (Control) and in responses to IGF1. Dotted line represents plateau 501 
enrichment.* Significantly different from baseline P<0.05, *** P<0.001, **** 502 
P<0.0001. § significantly different from control at that time point P<0.01  503 
 504 
Figure 4. A) MPE of RNA bound ribose from control and exercised rat quadriceps B) 505 
FSR of RNA from control and exercised rat quadriceps C) correlation between 506 
quadriceps MPS%.d
-1
 and RNA FSR%.d
-1
. Dotted line represents plateau enrichment 507 
*** Significantly different than control P<0.001 508 
 509 
Figure 5. A) Time course of body water enrichment measured through saliva samples 510 
over the 6 weeks of labeling B) MPE of RNA bound ribose from human VL in rest and 511 
 25 
RET legs. Dotted line represents the average plateau PBMC enrichment C) FSR of 512 
RNA bound ribose from human VL in rest and RET legs D) correlation between VL 513 
MPS%.d
-1
 and RNA FSR %.d
-1
.  *** Significantly different from baseline P<0.001 § 514 
Significantly different from control at that time point P<0.05 515 
  516 
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